Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Neuronal intranuclear inclusion disease is genetically heterogeneous
Chen, Zhongbo , Yau, Wai Yan , Tucci, Arianna , Sivakumar, Prasanth, Turner, Chris, Efthymiou, Stéphanie , Ibáñez, Kristina , Sullivan, Roisin , Bibi, Farah , Athanasiou‐Fragkouli, Alkyoni , Bourinaris, Thomas, Révész, Tamás , Lashley, Tammaryn , DeTure, Michael , Josephs, Keith A. , Gelpí, Ellen , Kovács, Gábor G. , Halliday, Glenda M. , Rowe, Dominic B. , Blair, Ian P. , Tienari, Pentti J. , Suomalainen, Anu , Fox, Nick C. , Wood, Nicholas , Haltia, Matti, Hardy, John , Ryten, Mina , Vandrovcová, Jana , Houlden, Henry , Yan Yau, Wai , Sullivan, Roisin , Dickson, Dennis W , Josephs, Keith A , Kovacs, Gabor G , Halliday, Glenda , Hardy, John , Gelpi, Ellen , Fox, Nick C , Houlden, Henry , Vandrovcova, Jana , Jaunmuktane, Zane , Taliun, Sarah A. Gagliano , Zhang, David , Lashley, Tammaryn , Dickson, Dennis W. , Lees, Andrew John , Wood, Nicholas

Mayo Clinic

Annals of Clinical and Translational Neurology | August 10, 2020 | Volume: 7 | Issue: 9 | Pages: 1716-1725

10.1002/acn3.51151 | PMID 32777174 Get It

AbstractNeuronal intranuclear inclusion disease (NIID) is a clinically heterogeneous neurodegenerative condition characterized by pathological intranuclear eosinophilic inclusions. A CGG repeat expansion in NOTCH2NLC was recently identified to be associated with NIID in patients of Japanese descent. We screened pathologically confirmed European NIID, cases of neurodegenerative disease with intranuclear inclusions and applied in silico‐based screening using whole‐genome sequencing data from 20 536 participants in the 100 000 Genomes Project. We identified a single European case harbouring the pathogenic repeat expansion with a distinct haplotype structure. Thus, we propose new diagnostic criteria as European NIID represents a distinct disease entity from East Asian cases.
Children of Divorce amid Allegations of Violence Need Clinical Child Expertise: Adapting Empirically Supported Interventions
Champion, Kelly M. , Trane, Sarah T.

Mayo Clinic

Evidence-Based Practice in Child and Adolescent Mental Health | August 10, 2020 | Volume: 5 | Issue: 3 | Pages: 365-378

10.1080/23794925.2020.1784059 Get It

Practice patterns and recommendations for pediatric image‐guided radiotherapy: A Children's Oncology Group report
Hua, Chia‐Ho , Vern-Gross, T.Z., Olch, Arthur J. , Alaei, Parham , Sathiaseelan, Vythialingam, Ulin, Kenneth, Laurie, Fran, Gopalakrishnan, Mahesh , Krasin, Matthew J. , Merchant, Thomas E. , Donaldson, Sarah S. , FitzGerald, Thomas J. , Haas‐Kogan, Daphne A. , Mahajan, Anita , Marcus, Karen J. , Taylor, Paige A. , Ahern, Verity , Followill, D , Breneman, John C. , Kalapurakal, John A. , Hodgson, David , Vern-Gross, Tamara Z, Wolden, Suzanne , Merchant, Thomas E , Donaldson, Sarah S , FitzGerald, Thomas J , Hodgson, David C , Laack, Nadia N Issa , Krasin, Matthew J , Taylor, Paige , Hodgson, David , Hess, Clayton Burnett , Deng, Jun , Gopalakrishnan, Mahesh, Esiashvili, Natia , Wolden, Suzanne L. , Constine, Louis S , Laack, Nadia N. , Buchsbaum, Jeffrey Craig

Mayo Clinic

Pediatric Blood & Cancer | August 10, 2020 | Volume: 67 | Issue: 10 | Pages: No page available

10.1002/pbc.28629 | PMID 32776500 Get It

AbstractThis report by the Radiation Oncology Discipline of Children's Oncology Group (COG) describes the practice patterns of pediatric image‐guided radiotherapy (IGRT) based on a member survey and provides practice recommendations accordingly. The survey comprised of 11 vignettes asking clinicians about their recommended treatment modalities, IGRT preferences, and frequency of in‐room verification. Technical questions asked physicists about imaging protocols, dose reduction, setup correction, and adaptive therapy. In this report, the COG Radiation Oncology Discipline provides an IGRT modality/frequency decision tree and the expert guidelines for the practice of ionizing image guidance in pediatric radiotherapy patients.
The COVID‐19 pandemic: A community approach
Cravedi, Paolo , Safa, Kassem , Kates, Olivia S. , Elfadawy, Nissreen , Mannon, Roslyn B. , Shah, Malay B. , Miranda, Cesar Guerrero, Jowsey‐Gregoire, Sheila G. , Camirand, Geoffrey , Azzi, Jamil , Safa, Kassem , Kates, Olivia S , Elfadawy, Nissreen , Mannon, Roslyn B , Riella, Leonardo V , Jowsey-Gregoire, Sheila, Azzi, Jamil , Schold, Jesse D , Hammond, Sarah P. , Avery, Robin K , Riella, Leonardo V. , Akalin, Enver , Alegre, Maria‐Luisa

Mayo Clinic

Clinical Transplantation | August 7, 2020 | Volume: 34 | Issue: 11 | Pages: No page available

10.1111/ctr.14059 | PMID 32762055 Get It

AbstractAn unprecedented global pandemic caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) has quickly overwhelmed the health care systems worldwide. While there is an absence of consensus among the community in how to manage solid organ transplant recipients and donors, a platform provided by the American Society of Transplantation online community “Outstanding Questions in Transplantation,” hosted a collaborative multicenter, multinational discussions to share knowledge in a rapidly evolving global situation. Here, we present a summary of the discussion in addition to the latest published literature.
Assessing Induced Emotions in Employees in a Workplace Setting Using Wearable Devices
Fortune, Emma , Yusuf, Yaqoub, Zornes, Sarah, Lopez, Jorge Loyo, Blocker, Renaldo C.

Mayo Clinic

2020 Design of Medical Devices Conference | August 6, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/dmd2020-9062 Get It

Abstract A working environment which elicits positive emotions in employees is vital for employee retention, engagement and productivity. Wearable sensors provide the means to objectively measure the emotional responses of employees in the workplace in real-time. The study aim was to perform a preliminary investigation into the validity of two multimodal systems to classify employee’s emotional responses to positive, neutral or negative video stimuli: (1) using wearable electroencephalography (EEG) in combination with video-based facial expression analysis (FEA), and (2) using a wearable galvanic skin response (GSR) device in combination with video-based FEA. Five office employees each watched three short video clips at three time points during their regular work shifts while wearing EEG sensors on the forehead and GSR sensors on the middle and index fingers of their non-dominant hand with their face in view of a webcam. Russel’s circumplex model of affect was used to determine participant’s emotional responses to the video clips. The GSR device showed greater accuracy than the EEG device at detecting arousal responses to the video stimuli, with agreement, precision, and recall values of 87%, 100% and 80%, respectively, compared to 53%, 62%, and 80% for the EEG device. The FEA/EEG and FEA/GSR circumplex models were both able to accurately detect positive emotions elicited from video stimuli with levels of agreement and recall greater than 73%. Precision for the FEA/EEG model to detect positive stimuli was lower due to misclassification of 40% of both negative and neutral stimuli as positive. Precision values for both circumplex models were very low for detecting negative emotions. The results suggest that the EEG and GSR devices may be capable of detecting arousal when used alone, and detecting positive emotions when used in combination with video-based FEA in real-time in the workplace.
Effect of Pause Procedures on Participant Reflection and Commitment-to-Change in Continuing Medical Education
Ratelle, John T. , Wittich, Christopher M. , Yu, Roger , Newman, James , Jenkins, Sarah M. , Beckman, Thomas J. , Newman, James S.

Mayo Clinic

Teaching and Learning in Medicine | August 4, 2020 | Volume: 32 | Issue: 5 | Pages: 552-560

10.1080/10401334.2020.1779070 | PMID 32749160 Get It

Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies
Wyld, Lynda , Bellantuono, Ilaria , Turner, Olivia, Foss, Fiona, George, Jayan , Kirkland, James L. , Tchkonia, Tamara, George, Jayan , Tchkonia, Tamar , Morgan, Jenna L. , Danson, Sarah J.

Mayo Clinic

Cancers | August 3, 2020 | Volume: 12 | Issue: 8 | Pages: 2134

10.3390/cancers12082134 | PMID 32752135 Get It

Cellular senescence is a key component of human aging that can be induced by a range of stimuli, including DNA damage, cellular stress, telomere shortening, and the activation of oncogenes. Senescence is generally regarded as a tumour suppressive process, both by preventing cancer cell proliferation and suppressing malignant progression from pre-malignant to malignant disease. It may also be a key effector mechanism of many types of anticancer therapies, such as chemotherapy, radiotherapy, and endocrine therapies, both directly and via bioactive molecules released by senescent cells that may stimulate an immune response. However, senescence may contribute to reduced patient resilience to cancer therapies and may provide a pathway for disease recurrence after cancer therapy. A new group of drugs, senotherapies, (drugs which interact with senescent cells to interfere with their pro-aging impacts by either selectively destroying senescent cells (senolytic drugs) or inhibiting their function (senostatic drugs)) are under active investigation to determine whether they can enhance the efficacy of cancer therapies and improve resilience to cancer treatments. Senolytic drugs include quercetin, navitoclax, and fisetin and preclinical and early phase clinical data are emerging of their potential role in cancer treatments, although none are yet in routine use clinically. This article provides a review of these issues.
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons
Mohan, Radhe , Liu, Amy , Brown, Paul D. , Mahajan, Anita , Dinh, Jeffrey, Chung, Caroline , McAvoy, Sarah , McAleer, Mary Frances , Ghia, Amol J. , Zhu, Cong , Sulman, Erik P. , Heimberger, Amy B. , McGovern, Susan L. , Ellsworth, Susannah G. , Grosshans, David R. , Sulman, Erik P , Lin, Steven H. , Li, Jing , Groot, John de , Heimberger, Amy B. , Grassberger, Clemens , Shih, Helen A.

Mayo Clinic

Neuro-Oncology | July 31, 2020 | Volume: 23 | Issue: 2 | Pages: 284-294

10.1093/neuonc/noaa182 | PMID 32750703 Get It

Abstract Background We investigated differences in radiation-induced grade 3+ lymphopenia (G3+L), defined as an absolute lymphocyte count (ALC) nadir of <500 cells/µL, after proton therapy (PT) or X-ray (photon) therapy (XRT) for patients with glioblastoma (GBM). Methods Patients enrolled in a randomized phase II trial received PT (n = 28) or XRT (n = 56) concomitantly with temozolomide. ALC was measured before, weekly during, and within 1 month after radiotherapy. Whole-brain mean dose (WBMD) and brain dose-volume indices were extracted from planned dose distributions. Univariate and multivariate logistic regression analyses were used to identify independent predictive variables. The resulting model was evaluated using receiver operating characteristic (ROC) curve analysis. Results Rates of G3+L were lower in men (7/47 [15%]) versus women (19/37 [51%]) (P < 0.001), and for PT (4/28 [14%]) versus XRT (22/56 [39%]) (P = 0.024). G3+L was significantly associated with baseline ALC, WBMD, and brain volumes receiving 5‒40 Gy(relative biological effectiveness [RBE]) or higher (ie, V5 through V40). Stepwise multivariate logistic regression analysis identified being female (odds ratio [OR] 6.2, 95% confidence interval [CI]: 1.95‒22.4, P = 0.003), baseline ALC (OR 0.18, 95% CI: 0.05‒0.51, P = 0.003), and whole-brain V20 (OR 1.07, 95% CI: 1.03‒1.13, P = 0.002) as the strongest predictors. ROC analysis yielded an area under the curve of 0.86 (95% CI: 0.79–0.94) for the final G3+L prediction model. Conclusions Sex, baseline ALC, and whole-brain V20 were the strongest predictors of G3+L for patients with GBM treated with radiation and temozolomide. PT reduced brain volumes receiving low and intermediate doses and, consequently, reduced G3+L.
Isolated Scaphoid Dislocation: A Case Report and Review of the Literature
Amundsen, Asgeir , Bishop, Sarah N. , Moran, Steven L.

Mayo Clinic

Journal of Wrist Surgery | July 30, 2020 | Volume: 09 | Issue: 05 | Pages: 431-439

10.1055/s-0040-1710395 | PMID 33042647 Get It

Abstract Background Isolated scaphoid dislocation is an exceedingly rare event with only 55 cases described. Closed reduction followed by operative intervention with Kirschner's wires (K-wire) fixation and ligamentous reconstruction are the mainstays of treatment. Case Description We describe a patient with a solitary scaphoid dislocation treated with initial closed reduction and urgent open reduction with K-wire stabilization and ligamentous repair. The patient was immobilized for 6 weeks and on 24-month follow-up, the patient was doing well with no limitations in his daily living, no pain, and acceptable range of motion. Literature Review A literature review was performed on the 55 cases described in the English language. The majority of the patients were males, aged between 18 and 79 years, and presented with motor vehicle accidents as the most common mechanism. Historically, isolated scaphoid dislocations were treated with closed reduction. However, K-wire fixation and, now, K-wire fixation coupled with ligamentous injury repair remain the current treatments of choice. Avascular necrosis of the scaphoid remains a rare event with only one documented case. Overall, patients do well with only minor pain and limited wrist movements. Notably, only eight cases were associated with type-II lunates. Type-II lunates appear to be protective for carpal injury. Clinical Relevance Although isolated scaphoid dislocations remain a rare event, understanding the anatomy and the current ability to restore carpal anatomy is important. Type-II lunates appear to confer protection from carpal injuries.